NYSE:NAVB
Delisted

Navidea Biopharmaceuticals Stock Insider Trading

etoro logo Buy NAVB
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Dec 30, 2025

Navidea Biopharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 51.36M and sold 42.22K NAVB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 51.36M shares
Sell 42.22K shares
88% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Oct 31, 2022
Buy
Common Stock
A-Award
Bhalla Amit
Director
Director 2 500
Value: $0
Oct 31, 2022
Buy
Common Stock
A-Award
Cappello Alexander L
Director
Director 2 500
Value: $0
Oct 31, 2022
Buy
Common Stock
A-Award
Scott John K Jr.
Director
Director 2 500
Value: $0
Oct 31, 2022
Buy
Common Stock
A-Award
Witter Malcolm G
Director
Director 2 500
Value: $0
Sep 30, 2022
Buy
Common Stock
J-Other
Wilson Joshua M.
Insider
Unknown 0
Value: $0
Sep 30, 2022
Buy
Common Stock
J-Other
Wilson Joshua M.
Director 0
Value: $0
Sep 30, 2022
Buy
Common Stock
J-Other
Wilson Joshua M.
Director 0
Value: $0
Sep 30, 2022
Buy
Common Stock
J-Other
Wilson Joshua M.
Insider
Unknown 0
Value: $0
Sep 30, 2022
Buy
Common Stock
A-Award
Witter Malcolm G
Director
Director 2 500
Value: $0
Sep 30, 2022
Buy
Common Stock
A-Award
Cappello Alexander L
Director
Director 2 500
Value: $0
Sep 30, 2022
Buy
Common Stock
A-Award
Scott John K Jr.
Director
Director 2 500
Value: $0
Sep 30, 2022
Buy
Common Stock
A-Award
Bhalla Amit
Director
Director 2 500
Value: $0
Sep 30, 2022
Buy
Common Stock
A-Award
Bhalla Amit
Director
Director 2 500
Value: $0
Sep 30, 2022
Buy
Common Stock
A-Award
Scott John K Jr.
Director
Director 2 500
Value: $0
Sep 30, 2022
Buy
Common Stock
A-Award
Cappello Alexander L
Director
Director 2 500
Value: $0
Sep 30, 2022
Buy
Common Stock
A-Award
Witter Malcolm G
Director
Director 2 500
Value: $0
Aug 31, 2022
Buy
Common Stock
A-Award
Cappello Alexander L
Director 2 500
Value: $0
Aug 31, 2022
Buy
Common Stock
A-Award
Bhalla Amit
Director 2 500
Value: $0
Aug 31, 2022
Buy
Common Stock
A-Award
Bhalla Amit
Director 2 500
Value: $0
Aug 31, 2022
Buy
Common Stock
A-Award
Cappello Alexander L
Director 2 500
Value: $0
Aug 30, 2022
Buy
Common Stock
A-Award
Witter Malcolm G
Director 2 500
Value: $0
Aug 30, 2022
Buy
Series I Convertible Preferred Stock
P-Purchase
Witter Malcolm G
Director
Director 115
Value: $52
Aug 30, 2022
Buy
Warrant to Purchase Common Stock
P-Purchase
Witter Malcolm G
Director
Director 115
Value: $58
Aug 30, 2022
Buy
Warrant to Purchase Common Stock
P-Purchase
Witter Malcolm G
Director 115
Value: $0
Aug 30, 2022
Buy
Common Stock
A-Award
Scott John K Jr.
Director 2 500
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT NAVIDEA BIOPHARMACEUTICALS INC
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission c...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
OSW
$24.00
17.08% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE